FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

370231006: Opiate agonist-antagonist (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2008. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1195522014 Opiate agonist-antagonist (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1208982016 Opiate agonist-antagonist en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1195522014 Opiate agonist-antagonist (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1195522014 Opiate agonist-antagonist (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1208982016 Opiate agonist-antagonist en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1208982016 Opiate agonist-antagonist en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Opiate agonist-antagonist Is a Analgesic (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Dezocine Is a False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Pentazocine lactate Is a False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Pentazocine hydrochloride Is a False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    bromhydrate de phénazocine Is a False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Qualitative measurement of opiate agonist Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Alfentanil measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Alphaprodine measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Anileridine measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Codeine measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Dextromoramide measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Diamorphine measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Mersalyl measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Oxycodone measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Methylfentanyl measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Norfentanyl measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    6-beta-Naltrexol measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    6-Monoacetylmorphine measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Moricizine measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Oxymorphone measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Paramethadione measurement (procedure) Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Despropionylfentanyl measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Methadone, long acting metabolite measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Oxycodeinone measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Opioid screening Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Urine methadone measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Urine morphine measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Methadone measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Urine codeine measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Urine opiate measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Serum morphine measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine 400micrograms sublingual tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine 2mg sublingual tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine (as buprenorphine hydrochloride) 200 microgram sublingual tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    buprénorphine 300 microgrammes/mL, ampoule de 1 mL de solution pour injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Nalbuphine hydrochloride 10mg/1mL injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    chlorhydrate de nalbuphine 10 mg/mL, ampoule de 2 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Pentazocine 30mg/mL injection solution 1mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Pentazocine 60mg/2mL injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Pentazocine (as pentazocine lactate) 50 mg rectal suppository The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Benzomorphan opioid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Dimethadione measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Opiate agonist-antagonist product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Butorphanol product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely butorphanol tartrate 10 milligram/1 milliliter conventional release nasal spray (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Nalbuphine product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Butorphanol tartrate 2mg/mL injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Butorphanol tartrate 1mg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Nalbuphine hydrochloride 20mg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Aspirin + pentazocine hydrochloride 325mg/ns tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Acetaminophen + pentazocine hydrochloride 650mg/ns caplet (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Naloxone hydrochloride + pentazocine hydrochloride 0.5mg/ns tablet (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Dextropropoxyphene Is a False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Dihydrocodeine Is a False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Phenazocine (substance) Is a False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Dextromoramide Is a False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Serum methadone level (procedure) Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Urine diamorphine level (procedure) Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Oral fluid opiate level (procedure) Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Oral fluid morphine level (procedure) Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Oral fluid methadone level (procedure) Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Urine methadone metabolite level Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing pentazocine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Meperidine measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Dihydromorphinone measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Opiates Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Trimethadione measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Quantitative measurement of opiate agonist Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Nalorphine measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Dihydrocodeinone measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Morphine measurement, quantitative Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Morphine measurement screening Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Butorphanol-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing buprenorphine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing nalbuphine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Nalbuphine hydrochloride [central nervous system use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Nalbuphine hydrochloride [anesthesia] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine 70micrograms/hour transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine 52.5micrograms/hour transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine 35micrograms/hour transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride + naloxone hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine 35micrograms/hour transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine 52.5micrograms/hour transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Buprenorphine 70micrograms/hour transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely pentazocine hydrochloride 50 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Pentazocine hydrochloride 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing nalbuphine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Acetaminophen + pentazocine hydrochloride 650mg/ns caplet (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Aspirin + pentazocine hydrochloride 325mg/ns tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Naloxone hydrochloride + pentazocine hydrochloride 0.5mg/ns tablet (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Acetaminophen + pentazocine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing naloxone hydrochloride and pentazocine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Aspirin + pentazocine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Dihydrocodeine measurement (procedure) Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Urine dihydrocodeine measurement Component False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing buprenorphine and naloxone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opiate agonist-antagonist Inferred relationship Existential restriction modifier (core metadata concept)

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    SAME AS association reference set (foundation metadata concept)

    Back to Start